Menopause is a window into the next thirty years. We use it.
The changes that matter most after menopause are the ones you cannot feel: bone loss, shifting lipids, changing insulin sensitivity. They are silent — and they are modifiable.
Silent, significant, and largely modifiable.
Bones
Bone loss is most rapid in the first years after the final period, raising fracture risk at the spine and hip. In the Women's Health Initiative, hormone therapy reduced hip fractures by roughly a third.
Heart
Women's premenopausal advantage over men narrows through the transition. The American Heart Association recognizes menopause as a window of increased cardiovascular risk.
Brain
Perimenopausal “brain fog” is real and documented — verbal memory dips during the transition. For most women, cognition returns toward baseline afterward; we address the modifiable contributors.
Metabolism
Insulin sensitivity, weight distribution, and lipids shift with the transition — changes that compound quietly over decades if left unaddressed.
What we actually do about it
Screening and treatment are built into every menopause plan here — not referred out piecemeal. Bone density testing before the first fracture rather than after. Formal cardiovascular risk assessment and lipid management. Metabolic evaluation when weight or glucose is shifting. Thyroid testing when symptoms overlap. One physician, one coordinated plan, reviewed over years.
Two honest boundaries, because evidence-based care means saying them: hormone therapy is not used to prevent or treat dementia, and it is not used for primary or secondary prevention of cardiovascular disease. Its indications are symptom relief, prevention of bone loss, and treatment of genitourinary symptoms. The rest of long-term health is managed with the tools built for it.